Hypofractionated radiotherapy in ten fractions for postmastectomy patients: A phase II study compared with another hypofractionation schedule with sixteen fractions
The purpose of this phase II study was to evaluate the feasibility of hypofractionated radiotherapy (HFRT) with a dose of 36.5Gy in 10 fractions in postmastectomy patients. From March 2014 to December 2015, 85 patients with locally advanced breast cancer were eligible to participate in this study with a schedule of 36.5Gy in 10 fractions.